Kurma Partners is a European venture capital firm specializing in healthcare, biotechnology, and environmental science investments. The firm focuses on transforming disruptive scientific discoveries into cutting-edge medicines and medical devices, targeting severe diseases with high unmet medical needs. Kurma Partners has built a strong network with leading European academic research institutions to identify and develop innovative healthcare solutions.
The firm's unique approach involves working closely with top European research centers to build the healthcare industry of tomorrow. Notable portfolio companies include Armgo Pharma and Mila. Kurma Partners invests across various stages, including seed and Series B rounds, demonstrating their commitment to supporting companies throughout their growth journey. Their investment philosophy emphasizes high standards and a focus on creating impactful healthcare solutions.
Kurma Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages